CTX-CNF1 Recombinant Protein Selectively Targets Glioma Cells In Vivo

Current strategies for glioma treatment are only partly effective because of the poor selectivity for tumoral cells. Hence, the necessity to identify novel approaches is urgent. Recent studies highlighted the effectiveness of the bacterial protein cytotoxic necrotizing factor 1 (CNF1) in reducing tu...

Descripción completa

Detalles Bibliográficos
Autores principales: Vannini, Eleonora, Mori, Elisabetta, Tantillo, Elena, Schmidt, Gudula, Caleo, Matteo, Costa, Mario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7998600/
https://www.ncbi.nlm.nih.gov/pubmed/33800135
http://dx.doi.org/10.3390/toxins13030194

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7998600/
https://www.ncbi.nlm.nih.gov/pubmed/33800135
http://dx.doi.org/10.3390/toxins13030194

Ejemplares similares